8.900
+0,00%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -89.6% | -42.0% | 1 / 3 | +624.8% | -88.53 pp | -851.47 pp | +7.4% | 0.00 | 9.06 | 4,9 | +624,8% | 0,6 | −89,6% | 9.06 | 6.99 | +29,6% |
| Pts | 0 | 0 | 4 | 12 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 8.900 (close price on 2026-10-19)EPS (TTM): 982,1
Financial charts
1.Revenue & growth
VND bn5,05Q2/26
1.Revenue & growth
VND bn5,05Q2/26
2.Profit & growth
VND bn0,61Q2/26
3.Profit mix (Penman)
VND bn17,5Q2/26
4.Margins & cost structure
%16.6%Q2/26
5.Returns & cash cycle
% · days0.3%Q2/26
6.Earnings quality & cash
VND bn-5,93Q2/26
7.Asset structure
VND bn244Q2/26
8.Funding & debt health
VND bn · times244Q2/26
9.Revenue backlog
VND bn5,94Q2/26
10.Valuation
times · %9,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %35Q2/26
Adjusted EPS growth, latest quarter
-89.6%
Average adjusted EPS growth, 3 quarters
-42.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26